Looks to me like these are not anemia-related compounds.
It's only $1m because AKBA couldn't afford more - so I assume JNJ made up in royalties and milestones for the paltry upfront.
Basically neutral I think - the increased burn is the negative. It's possible AKBA understands something JNJ doesn't so could always be a hidden gem in there someplace.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.